406 related articles for article (PubMed ID: 23265089)
1. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.
Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC
Drug Alcohol Depend; 2013 Jun; 130(1-3):245-8. PubMed ID: 23265089
[TBL] [Abstract][Full Text] [Related]
2. [Consumption of psilocybin-containing hallucinogenic mushrooms by young people].
Lassen JF; Lassen NF; Skov J
Ugeskr Laeger; 1992 Sep; 154(39):2678-81. PubMed ID: 1413197
[TBL] [Abstract][Full Text] [Related]
3. Hallucinogenic mushrooms.
Schwartz RH; Smith DE
Clin Pediatr (Phila); 1988 Feb; 27(2):70-3. PubMed ID: 3338231
[TBL] [Abstract][Full Text] [Related]
4. [Hallucinogenic mushrooms].
Reingardiene D; Vilcinskaite J; Lazauskas R
Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
[TBL] [Abstract][Full Text] [Related]
5. Evidence for significant polydrug use among ecstasy-using college students.
Wish ED; Fitzelle DB; O'Grady KE; Hsu MH; Arria AM
J Am Coll Health; 2006; 55(2):99-104. PubMed ID: 17017306
[TBL] [Abstract][Full Text] [Related]
6. Between prohibitions: patterns and meanings of magic mushroom use in the UK.
Riley SC; Blackman G
Subst Use Misuse; 2008; 43(1):55-71. PubMed ID: 18189205
[TBL] [Abstract][Full Text] [Related]
7. [Automutilation after consumption of hallucinogenic mushrooms].
Attema-de Jonge ME; Portier CB; Franssen EJ
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
[TBL] [Abstract][Full Text] [Related]
8. Peculiar plants and fantastic fungi: An ethnobotanical study of the use of hallucinogenic plants and mushrooms in Slovenia.
Fatur K
PLoS One; 2021; 16(1):e0245022. PubMed ID: 33412556
[TBL] [Abstract][Full Text] [Related]
9. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
10. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
[TBL] [Abstract][Full Text] [Related]
11. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
Lyvers M; Meester M
J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
[TBL] [Abstract][Full Text] [Related]
12. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
Leonard JB; Anderson B; Klein-Schwartz W
J Psychopharmacol; 2018 Dec; 32(12):1286-1294. PubMed ID: 30182795
[TBL] [Abstract][Full Text] [Related]
13. Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.
Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P
J Psychopharmacol; 2020 Sep; 34(9):999-1007. PubMed ID: 32674668
[TBL] [Abstract][Full Text] [Related]
14. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
Jastrzebski M; Bala A
Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
[TBL] [Abstract][Full Text] [Related]
15. Substance abuse on the college campus.
Rimsza ME; Moses KS
Pediatr Clin North Am; 2005 Feb; 52(1):307-19, xii. PubMed ID: 15748936
[TBL] [Abstract][Full Text] [Related]
16. Mushroom use by college students.
Thompson JP; Anglin MD; Emboden W; Fisher DG
J Drug Educ; 1985; 15(2):111-24. PubMed ID: 4020593
[No Abstract] [Full Text] [Related]
17. Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.
Cuomo MJ; Dyment PG; Gammino VM
J Am Coll Health; 1994 May; 42(6):271-4. PubMed ID: 7913938
[TBL] [Abstract][Full Text] [Related]
18. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
Musshoff F; Madea B; Beike J
Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
[TBL] [Abstract][Full Text] [Related]
19. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.
Petranker R; Anderson T; Maier LJ; Barratt MJ; Ferris JA; Winstock AR
J Psychopharmacol; 2022 Jan; 36(1):85-96. PubMed ID: 33591231
[TBL] [Abstract][Full Text] [Related]
20. Increasing MDMA use among college students: results of a national survey.
Strote J; Lee JE; Wechsler H
J Adolesc Health; 2002 Jan; 30(1):64-72. PubMed ID: 11755802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
